Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04600830
Other study ID # UCV/2019 - 2020/062
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2020
Est. completion date May 10, 2021

Study information

Verified date May 2021
Source Fundación Universidad Católica de Valencia San Vicente Mártir
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare the effects of dry needling and Foam roller in myofascial trigger points. Needling has been shown to decrease pain in the short term; however, its effects on muscle force production are unclear. There are differences between dry needling and foam roller after treatment?


Description:

Background: It has been shown that the decrease of the range of motion in the ankle, due to the presence of latent trigger points in the gastro-sole complex, can affect performance, as well as being a predisposing factor to injury. Objective: To compare the effects of Dry Needling and Foam roller in healthy athletes with limited dorsal ankle flexion by the presence of latent trigger points. Material and methods: This is a clinical trial, single-blind experimental study. The sample will have a total of 44 students, volunteers, healthy of the degree of physiotherapy of the the investigator's university (UCV). Participants who meet the inclusion criteria will be randomly assigned in two groups: Group 1 or Dry Needling (N = 22) and Group 2 or Foam Roller (N = 22). The range of motion of ankle will be assessed through the Leg Motion system (Check Your Motion®, Albacete, Spain). Assessed thought Ankle Test (post-intervention and 24 hours later). The reference values to consider the decreased ankle ROM will be <11.5 cm, <35º measured with Easy Angle® digital goniometer (Meloq AB, Sweden) and/or if it has a difference of 1.5 cm between both extremities. Thus, the effect on previous activity performance will be assessed thought the Counter Movement Jump. Data analysis: Once the distribution of the sample is determined, a descriptive analysis of the data will be carried out and an ANOVA of repeated measures. Will be used to compare the data found in the two groups that make up the study taking into account a 95% CI and an error less than 0.05.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date May 10, 2021
Est. primary completion date May 15, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Students of physiotherapy degree of the university - All participants who present restriction on active ankle dorsiflexion (<35º). - They must be diagnosed through manual therapy of latent PG in the gastro-soleus complex. Exclusion Criteria: - Subjects suffering from belonephobia - Pathology of connective tissue - Coagulation problems - Lymphatic disorders - Diabetes - Surgical history in the lower limb (last 12 months) - Prior treatment with dry needling (last 6 months)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Dry needling
Intervention with deep dry needling on latent myofascial trigger points (MTrPs) in gastrocnemius muscle.

Locations

Country Name City State
Spain Juan Vicente Mampel Valencia

Sponsors (1)

Lead Sponsor Collaborator
Fundación Universidad Católica de Valencia San Vicente Mártir

Country where clinical trial is conducted

Spain, 

References & Publications (5)

Calatayud J, Martin F, Gargallo P, García-Redondo J, Colado JC, Marín PJ. The validity and reliability of a new instrumented device for measuring ankle dorsiflexion range of motion. Int J Sports Phys Ther. 2015 Apr;10(2):197-202. — View Citation

de Benito AM, Valldecabres R, Ceca D, Richards J, Barrachina Igual J, Pablos A. Effect of vibration vs non-vibration foam rolling techniques on flexibility, dynamic balance and perceived joint stability after fatigue. PeerJ. 2019 Nov 26;7:e8000. doi: 10.7717/peerj.8000. eCollection 2019. — View Citation

Gerwin RD. A review of myofascial pain and fibromyalgia--factors that promote their persistence. Acupunct Med. 2005 Sep;23(3):121-34. Review. — View Citation

Grieve R, Clark J, Pearson E, Bullock S, Boyer C, Jarrett A. The immediate effect of soleus trigger point pressure release on restricted ankle joint dorsiflexion: A pilot randomised controlled trial. J Bodyw Mov Ther. 2011 Jan;15(1):42-9. doi: 10.1016/j.jbmt.2010.02.005. Epub 2010 Mar 23. — View Citation

Grieve R, Goodwin F, Alfaki M, Bourton AJ, Jeffries C, Scott H. The immediate effect of bilateral self myofascial release on the plantar surface of the feet on hamstring and lumbar spine flexibility: A pilot randomised controlled trial. J Bodyw Mov Ther. 2015 Jul;19(3):544-52. doi: 10.1016/j.jbmt.2014.12.004. Epub 2014 Dec 18. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Range of motion (ROM) Range of motion (ROM) is a key measurement to help in detecting and diagnosing musculoskeletal deficits, monitoring treatment progression, and guiding the treatment plan. Measurement of ROM is a relevant point and an important item of the joint evaluation process when using any ankle scoring system as part of the ankle and ankle joint evaluation. ROM of ankle joint in load PRE, POST treatment and POST 24 hours after of intervention. 48 hours
Secondary Lunge / Ankle Test Test he Weight-bearing lunge test (WBLT) or Dorsiflexion Lunge Test (DFT) is used to assess the dorsiflexion range of movement (DROM) at the ankle joint. Participants are instructed to lunge forward until their knee touches the wall (vertical line). The heel is required to remain in contact with the floor at all times. The foot is moved away from the wall to the point where the knee can only make slight contact with the Wall. 48 hours
Secondary Counter Movement Jump (CMJ) The countermovement jump (CMJ) is a simple, practical, valid, and very reliable measure of lower-body power. This suggests that performances in the CMJ are linked with maximal speed, maximal strength, and explosive-strength. When the CMJ is performed using the arm-swing, performances can be =10% higher than when they include no arm-swing. Contact mats, force platforms, accelerometers, high-speed cameras, and infrared platforms have all been shown to provide a valid and reliable measure of CMJ performance - though force platforms are considered as the 'gold-standard'. 48 hours
See also
  Status Clinical Trial Phase
Completed NCT03365674 - Vibration for Pain Reduction During Trigger Point Injection N/A
Completed NCT02924259 - Does Self-myofascial Release With a Foam Roll Change Pressure Pain Thresholds in Lower Extremity Muscles N/A
Completed NCT01381380 - Manual Therapy Treatment for Myofascial Pain N/A
Completed NCT04645095 - Which Type of Transcutaneous Electrical Nerve Stimulation is More Effective in Myofascial Pain Syndrome? N/A
Completed NCT05664165 - The Efficiency of Dry Needling and Cold Spray-stretching Treatments N/A
Completed NCT02889991 - Evolution of Myofascial Pain, Post-dry Needling. Repair and Measuring With Elastography, of Myofascial Tissue. N/A
Completed NCT00134810 - Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome Phase 2
Completed NCT01742546 - Effectiveness of Ultrasound Combine TENS in Treatment of Upper Trapezius Myofascial Pain N/A
Completed NCT01106989 - Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points Phase 2
Completed NCT00635037 - Myofascial Pain:Acupuncture Versus Trigger Point Injection Combined With Dipyrone and Cyclobenzaprine N/A
Completed NCT00241215 - Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome Phase 4
Terminated NCT02829814 - Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia Phase 3
Completed NCT01835795 - Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain N/A
Completed NCT00149240 - Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome Phase 2
Completed NCT05668728 - Dry Needling for Myofascial Pain Syndrome N/A
Recruiting NCT02381171 - Transcranial Magnetic Stimulation and/or Neurofunctional Electrical Acupuncture in Myofascial Chronic Pain Patients N/A
Completed NCT01032863 - Association Between Hypermobility and Chronic Musculoskeletal Pain N/A
Completed NCT04703803 - Efficacy of Myofascial Pain Syndrome Treatment in Patients With Cancer in Palliative Care Phase 3
Completed NCT05524623 - Comparative Effect of MEP With or Without Current Emission in the Treatment of Cervical Pain in MTrPs of the Trapezius N/A
Completed NCT04504409 - Comparison of Efficacy of Dry Needling and Kinesio-taping N/A